MedTrace Logo

Defects in Opsonophagocytosis in Premature Infants

NCT00866567 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2010-02-03

No results posted yet for this study

Summary

The purpose of the study is to characterize innate immune function of premature infants, and identify defects that may be responsible for the development of bacterial sepsis.

Conditions

  • Prematurity
  • Neonatal Sepsis

Sponsors & Collaborators

  • Gertrude Von Meissner Foundation

    collaborator OTHER

  • European Society of Intensive Care Medicine

    collaborator OTHER

  • Swiss National Fund for Scientific Research

    collaborator OTHER

  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Jerome PUGIN, MD · University Hospitals of Geneva

  • Michel BERNER, MD · University Hospitals of Geneva

  • Pierre TISSIERES, MD, MSc · University Hospitals of Geneva

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00866567 on ClinicalTrials.gov